What is PositionalCalls?

PositionalCalls is an independent Indian finance research platform founded by Shubham Chaudhary in 2023. It covers banking stocks, insurance companies, IPO analysis, earnings reports, and sector outlooks. All research is data-driven, unbiased, and updated daily.

Is PositionalCalls SEBI registered?

No. PositionalCalls is not SEBI registered. All content is for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell securities. Always consult a qualified SEBI-registered financial advisor before investing.

Who writes the research on PositionalCalls?

All research is written by Shubham Chaudhary, an independent market research analyst specialising in Indian banking, insurance, and equity markets. He tracks NSE and BSE-listed companies using fundamental analysis and institutional research frameworks.

How often is PositionalCalls updated?

PositionalCalls is updated daily. Research articles, IPO GMP updates, earnings analysis, and sector outlooks are published every trading day. Breaking corporate developments are covered on the same day.

What topics does PositionalCalls cover?

PositionalCalls covers Indian banking stocks, insurance sector analysis, IPO reviews, quarterly earnings results, sector outlooks for BFSI, IT, pharma, and auto, plus a Learning Hub with guides on fundamental analysis for retail investors.

Is PositionalCalls free to use?

Yes. All research articles on PositionalCalls are completely free. The WhatsApp Channel with daily stock alerts, IPO GMP updates, and earnings notifications is also free with no subscription or payment required.

How do I get PositionalCalls stock alerts on WhatsApp?

Join the free PositionalCalls WhatsApp Channel to receive daily IPO GMP updates, earnings alerts, banking sector signals, and positional stock picks every morning before the market opens. The channel has over 12,000 members.

Which Indian stock exchange does PositionalCalls track?

PositionalCalls tracks stocks listed on the NSE (National Stock Exchange) and BSE (Bombay Stock Exchange). Coverage includes Nifty 50, Bank Nifty, Nifty IT, and sector-specific indices relevant to banking and insurance investors.

What is positional trading in Indian stock markets?

Positional trading means holding stocks for days to months based on fundamental and technical research, unlike intraday trading. PositionalCalls focuses on this style — identifying quality companies at the right price for medium-to-long term holding periods.

How is PositionalCalls different from paid research services?

PositionalCalls has no brokerage affiliation, no paid promotions, and no conflict of interest. Unlike many paid SEBI-tip services, it focuses on education and analysis transparency — showing methodology, data sources, and valuation frameworks openly.

Positional Calls - Banking, Insurance & Stock Market Research India

Accretion Nutraveda IPO GMP Today: Grey Market Premium, Review, Subscription & Listing Outlook

6 February 202624 January 2026 by Shubham Chaudhary

Accretion Nutraveda IPO GMP Today: Analysis, GMP Trends, Subscription Structure, Smart Money Signals & Listing Probability 2026 Positional Calls Theme System | Institutional Research | Smart Money Intelligence Dashboard Institutional Alert Retail demand is expanding faster than institutional flows, while GMP remains stable in a narrow band. This structure indicates sentiment-driven momentum with selective smart-money … Read more

Modern Diagnostic IPO Review: Best SME IPO in healthcare sector 2025

29 December 2025 by Shubham Chaudhary

Modern Diagnostic IPO Key Details Modern Diagnostic & Research Centre Ltd. is coming with a pure, fresh-issue SME IPO of 4,099,200 equity shares, aggregating up to about ₹36.89 crore on the BSE SME platform. The price band has been fixed at ₹85–₹90 per share with a face value of ₹10. Key offer details: IPO type: … Read more

Corona Remedies IPO GMP Today: ₹300+ Gain?

6 December 2025 by Shubham Chaudhary

Corona Remedies IPO 2025: Snapshot Corona Remedies Ltd is a Gujarat-based pharmaceutical company focused on branded formulations, chronic therapies, and prescription-driven products in India. The IPO is a pure OFS of about 61.7 lakh shares, aggregating to ₹655.37 crore, with no fresh issue component. Key IPO details for quick reference: Parameter Details IPO type Mainboard, … Read more

Aequs IPO 2025: Detailed Review, GMP, Valuation & Listing Strategy

3 December 2025 by Shubham Chaudhary

Aequs IPO 2025: Main takeaway: The Aequs IPO is a ₹921.81 crore main-board issue in The Aequs IPO, which is part of the aerospace and precision manufacturing sector, is priced at ₹118–₹124 per share with a lot size of 120 shares, and it will be open from 3 to 5 December 2025. upcycle but comes … Read more

Buy Recommendation on Escorts Kubota — Detailed Analysis of Earnings, Business Model & Sector Risks (2025–2026)

9 February 20263 November 2025 by Shubham Chaudhary

Buy Recommendation on Escorts Kubota Analysis 2025–2026: Market Structure, Earnings & Risk Context Escorts Kubota Limited operates within India’s agricultural machinery and construction equipment ecosystem. This page documents observed price behaviour, disclosed financial performance, business positioning, and sector-level drivers using publicly available information. All references are informational in nature and do not constitute investment advice. … Read more

Pine Labs IPO 2025: Complete Investment Guide with Price Band, GMP, and Expert Analysis

1 November 2025 by Shubham Chaudhary

Pine Labs IPO 2025: Fintech major Pine Labs is set to launch its much-awaited Initial Public Offering (IPO) on November 7, 2025, marking a watershed moment for India’s digital payments ecosystem. With the company targeting to raise ₹2,080 crore through a fresh issue and offering significant exit opportunities for marquee investors like Peak XV Partners, … Read more

Groww IPO Analysis 2025: The Complete Investor’s Guide

30 October 2025 by Shubham Chaudhary

Groww IPO Analysis 2025: The Groww IPO is shaping up to be one of the most exciting financial events in India’s fintech landscape, promising blockbuster volume and wide participation from retail investors. Backed by industry veterans and global funds, Groww’s journey from a cutting-edge broking app to India’s leading digital wealth platform has been nothing … Read more

Buy Recommendation for Reliance Industries in 2025: A Comprehensive Stock Analysis and Investment Outlook

3 February 202629 October 2025 by Shubham Chaudhary

Buy Recommendation for Reliance Industries: 2025 Business Analysis, Growth Drivers & Risk Overview: Educational disclosure: This page is an analytical review based on publicly available information and market observations. It does not constitute investment advice. Market Context (Non-Advisory): Reliance Industries observed trading near ₹1500 Structural demand zone discussed by market participants near ₹1340 Upper reference … Read more

Lenskart IPO Share Price: Valuation, Investment Tips & Key Insights You Can’t Miss

28 October 2025 by Shubham Chaudhary

Lenskart IPO Share Price: A Game-Changer in the Indian eyewear industry The Lenskart Solutions IPO stands out as one of 2025’s most-anticipated public listings, capturing intense interest across retail and institutional investors alike. With global investors backing Lenskart, a fast-growing tech-driven eyewear retailer, investor expectations ride high on its record-breaking profitability, ambitious expansion strategy, and … Read more